IL-18BP also acts to reduce IL-18 agonist activity and an imbalance of IL-18 and IL-18BP has been described in Wegener’s granulomatosis and systemic lupus erythematosus (Novick et al., 2009, 2010). This evidence concerns the gene IL18BP and granulomatosis with polyangiitis.